Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients.
about
High-flux versus low-flux membranes for end-stage kidney diseaseHigh-flux versus low-flux haemodialysis membranes for end-stage renal diseaseDialysis-related amyloidosis: challenges and solutionsPush/pull hemodiafiltration: technical aspects and clinical effectiveness.Effects of High-Flux versus Low-Flux Membranes on Pulmonary Function Tests in Hemodialysis Patients.Nontransplant therapy for dialysis-related amyloidosis.Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.Quantification of middle molecular weight solute removal in dialysis.Impact of contaminated dialysate on long-term haemodialysis-related complications: is it really that important?Outcome of home haemodialysis patients: a case-cohort study.Quo vadis dialysis membrane?What is new in uremic toxicity?Special clinical problems in geriatric patients.Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic functionIncreased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.Properties of membranes used for hemodialysis therapy.Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort studyRemoval of middle molecules with sorbents.Dialyzer Reuse and Outcomes of High Flux DialysisThe genetics of the amyloidoses: interactions with immunity and inflammation.Effects of high versus low flux membranes on o2 saturation in hemodialysis patients.High-quality dialysis: a lesson from the Japanese experience: Effects of membrane material on nutritional status and dialysis-related symptoms.Effect of different synthetic membranes on laboratory parameters and survival in chronic haemodialysis patientsThe impact of membrane permeability and dialysate purity on cardiovascular outcomesThe MPO Study: just a European HEMO Study or something very different?Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer?KHA-CARI guideline: dialysis adequacy (haemodialysis): dialysis membranes.Rheumatic complications of long term treatment with hemodialysis.Ultrapure dialysis fluid: a new standard for contemporary hemodialysis.Subcutaneous beta2-microglobulin amyloid shoulder nodulesin a long-term hemodialysis patient.Dissociation between dialysis adequacy and Kt/V.Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.Dose of dialysis, convection and haemodialysis patients outcome--what the HEMO study doesn't tell us: the European viewpoint.Influence of dialysis modality and membrane flux on quality of life in hemodialysis patients.
P2860
Q24200387-3A79C684-41E6-43AE-A0B9-DF9CD7DCF103Q24246295-B5C6D8BE-E658-4621-B32F-CC5926FF40D5Q28075306-2DD6A723-6DED-412F-9F9E-C0372626FE06Q33808356-69BC0A7A-BDA9-46D5-90DC-250C7849CB78Q34126754-859B9C2E-714F-4E2C-B537-56D84B6B2DA4Q34192990-50C94DB3-90B7-4361-AC9A-8E7456B8296FQ34193006-0860DF80-CA3A-40A5-9C05-22E08F151E93Q34328361-665D630F-2483-41AB-B589-BE79084BB19EQ34381887-1B7EE5AF-C275-47A9-86E0-EA1153FF8E40Q34387131-676DF28A-E987-477A-B0D0-B186768982F9Q34552422-0D59C33C-89B3-4AE5-97D0-FDC47FBC636FQ34589157-18CC330D-CEC5-4374-ADED-BB177C5A36FDQ34600808-CA6D05BF-185D-4AF7-BE48-21FB8FA4FA34Q34645284-866F5C21-484F-4689-8C32-AE55C4ECABD0Q34706125-A47FEB04-1835-4DC9-A724-D64FD217CDC1Q34722874-55D59362-4790-4200-9E28-002885CDA906Q34937539-94247F22-5836-4888-8F32-910BAA50D138Q35049298-29440AD3-E00F-4B72-BAFB-143B5C2E336FQ35658056-4A8AE469-42A2-4035-A62E-7D61AAC20C3BQ36534748-FD5D1D97-9360-49A3-899F-81D2F3004A66Q36734482-D34C51C4-9661-465D-9302-C9E9EBA1A8BDQ36745399-78CA4E63-7849-4A1B-9600-291F8B170D70Q36745402-EBE15084-8EE6-4732-94A0-A4E8DC6C3187Q36880441-EE7D918E-E551-4327-9083-D97FDFE32155Q37053450-D4D8F906-DD67-4BB4-BB86-57999E03B66CQ37842757-730D4E1B-FD16-4924-8AC2-C4AD22B4F39AQ38106738-7D7B9FD9-E4E1-406B-ACB4-B744080DF726Q38864917-D7E0E56E-4DDB-409B-BD99-331051C0CBCCQ39512561-712690D6-B6D4-431A-9147-790296314B52Q39863017-2E848850-BBAD-4BB7-B268-CA2F37767D6DQ40656345-704DAA18-133C-4EEC-924C-09A48D34FD2DQ40701105-AC08C63D-AE4D-4942-9D2F-26D27A8F9419Q41072062-F53A0187-0505-43CE-B35A-1F8656BD478AQ44024076-F0B5DA58-C3E8-408F-9DA5-4D08FF7FFEE3Q44263992-5811B200-0E91-44CC-A54A-D65CCACA4649
P2860
Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Switch from conventional to hi ...... lity of hemodialysis patients.
@ast
Switch from conventional to hi ...... lity of hemodialysis patients.
@en
Switch from conventional to hi ...... lity of hemodialysis patients.
@nl
type
label
Switch from conventional to hi ...... lity of hemodialysis patients.
@ast
Switch from conventional to hi ...... lity of hemodialysis patients.
@en
Switch from conventional to hi ...... lity of hemodialysis patients.
@nl
prefLabel
Switch from conventional to hi ...... lity of hemodialysis patients.
@ast
Switch from conventional to hi ...... lity of hemodialysis patients.
@en
Switch from conventional to hi ...... lity of hemodialysis patients.
@nl
P2093
P356
P1433
P1476
Switch from conventional to hi ...... lity of hemodialysis patients.
@en
P2093
Haginoshita S
Hirasawa Y
Miyazaki S
Sakurabayashi T
P2888
P304
P356
10.1038/KI.1997.434
P407
P577
1997-10-01T00:00:00Z
P5875
P6179
1009844724